Medexus Pharmaceuticals (TSX:MDP) FCF Yield % : 32.52 (As of Mar. 23, 2025)

View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Medexus Pharmaceuticals's Trailing 12-Month Free Cash Flow is C$28.3 Mil, and Market Cap is C$87.1 Mil. Therefore, Medexus Pharmaceuticals's FCF Yield % for today is 32.52%.

The historical rank and industry rank for Medexus Pharmaceuticals's FCF Yield % or its related term are showing as below:

TSX:MDP' s FCF Yield % Range Over the Past 10 Years
Min: -45.68 Med: -6.3 Max: 75.1
Current: 32.52

During the past 13 years, the highest FCF Yield % of Medexus Pharmaceuticals was 75.10%. The lowest was -45.68%. And the median was -6.30%.

TSX:MDP's FCF Yield % is ranked better than
97.58% of 1032 companies
in the Drug Manufacturers industry
Industry Median: 0.145 vs TSX:MDP: 32.52

Medexus Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 22.03%.

Medexus Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Medexus Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals FCF Yield % Chart

Medexus Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Yield %

Get a 7-Day Free Trial

-10.15

-4.74

-17.97

-7.65

63.41

Medexus Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															49.19	19.10	100.50	35.81	44.05

Competitive Comparison of Medexus Pharmaceuticals's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medexus Pharmaceuticals's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's FCF Yield % falls into.

Medexus Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Medexus Pharmaceuticals's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	24.971	/	39.37738
	=	63.41%

Medexus Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	9.412	*	4	/	85.46892
	=	44.05%

Medexus Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Medexus Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

MEDXF:USA P731:Germany

Address

10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Executives

Brendon Buschman	Senior Officer
Mike Mueller	Director
Benoit Gravel	Director
Stephen William Nelson	Director
Kenneth D'entremont	Director, Senior Officer
Marcel Pascal Konrad	Senior Officer
Brian Peters	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Roland Boivin	Senior Officer
Michael Pine	Senior Officer
Glenn Tate	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Richard Labelle	Senior Officer
Benoît Hébert	Senior Officer